NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P102. A total of 27 filers reported holding NOVABAY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SOPHROSYNE CAPITAL LLC | 1,093,596 | $1,509,000 | 1.18% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 216,700 | $299,000 | 0.40% |
| GARRISON BRADFORD & ASSOCIATES INC | 138,000 | $190,000 | 0.20% |
| BUCKINGHAM STRATEGIC WEALTH, LLC | 54,808 | $76,000 | 0.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 25,000 | $35,000 | 0.02% |
| Spark Investment Management LLC | 30,500 | $42,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 121,500 | $168,000 | 0.01% |
| EP Wealth Advisors, LLC | 13,267 | $18,000 | 0.01% |
| ACG Wealth | 10,000 | $14,000 | 0.01% |
| GLENMEDE TRUST CO NA | 300,000 | $414,000 | 0.01% |